CALCA and migraine disorder: In view of this reasoning, constipation cannot be classified as an indirect effect of CGRP-directed migraine therapeutics, as hoped by Haanes et al. (2020), but need be regarded as the result of blockade of CGRP signaling in the neural pathways underlying intestinal motor activity and secretion.